Objective: A promising strategy in regenerative endodontics is the combination of human dental pulp stem cells (hDPSCs) with an appropriate biomaterial substrate.
Introduction
The high incidence of tooth decay and tooth loss combined with the limited regeneration capacities of dental tissues necessitates the development of novel strategies for dental practices [1] . Human dental pulp stem cells (hDPSCs) are a mesenchymal stem cell (MSC) population [2, 3] . Analogous to MSCs derived from bone marrow (BMSCs), hDPSCs can form alizarin red-positive mineralised deposits, physiologically similar to hydroxyapatite (HA) [2, 4] . Thus, experiments have been conducted to evaluate the value of hDPSCs in the repair of bone defects [5] [6] [7] . However, numerous studies have demonstrated that hDPSCs have a greater ability to differentiate into odontoblasts compared to BMSCs [2, 8] . Co-transplanting cultured hDSPCs with HA/TCP particles, into immunocompromised mice, led to the vascularisation of a fibrous pulp tissue surrounded by a layer of odontoblast-like cells, cells had extended tubular structures that resembling a dentine-like structure [2, 8] . In contrast, a lamellar bone structure with associated adipose tissue was formed by human BMSCs under the same experimental condition [2] . These findings clearly demonstrate distinct tissue regeneration capacities of hDPSCs and BMSCs, which appear to have maintained a level of epigenetic memory of their tissue origin [2] .
Somewhat unsurprisingly then, hDPSCs is the preferred derivation of cells for dental tissue engineering.
The fundamental concept in hard tissue engineering lies in combining a scaffold with living cells to repair damaged tissue [9] . Scaffolds provide a suitable environment for cell attachment, proliferation, differentiation and to promote biomineralisation [10] . A significant challenge regarding scaffold usage is the choice of a suitable material. A broad range of materials, natural or synthetic polymers and inorganics, have been designed as scaffolds for dentin-pulp regeneration [11] . Bioactive glasses (BGs) are a promising choice for repair and reconstruction of hard tissues, such as bone and dentine [12, 13] . BGs can form hydroxyapatite (HA) quickly, is biocompatible and can deliver 'therapeutic ions' [12, 14] .
In dental practice, the use of zinc (Zn) is mostly favoured owing to its bacteriostatic and cariostatic properties [15] . For example, Znoxide eugenol (ZOE), Zn oxyphosphate (ZOP), and Zn polycarboxylate (ZPC) are widely used.
However, despite the clinical advantages, the dentinogenic benefits of Zn have yet to be determined. Accordingly, we have focused on Zn and Zn containing BGs (ZnBGs) to characterise their effects on hDPSCs.
Materials and methods

Bioactive glass synthesis and characterisation
ZnBGs (compositions are shown in Fig.2A) were synthesised by the meltquench route [16] . Glass frits were grounded and sieved to powders ≤ 38µm.
The particle size and amorphous nature was confirmed by master particle size analyser and X-ray diffraction (XRD). ZnBGs powders were characterised as described previously [17] . Briefly, 75mg of BGs powder (≤ 38 µm) was added to 50 ml Tris buffer and incubated on an orbital shaker (60 rpm at 37 °C). Post shaking, the pH values were recorded. The solution was filtered, diluted by a factor of ten in distilled H 2 O and acidified with 69% nitric acid (final concentration 2%) prior to determining the elemental concentrations of calcium (Ca), phosphorus (P), silica (Si), and zinc (Zn) using an inductively coupled plasma-optical emission spectrometer (ICP-OES). The residual powders were dried overnight and analysed to evaluate the extent of apatite formation using XRD, and Fourier transform infrared spectroscopy (FTIR).
Cell culture
Human dental pulp stem cells (hDPSCs, Lonza) were cultured in Dulbecco's Modified Eagle Medium (DMEM, Lonza) supplemented with 10% fetal calf serum (FCS) and antibiotics (10U/L penicillin and 100mg/L streptomycin) in a humidified atmosphere with 10% CO 2 at 37 °C.
Free ionic Zn (0.5, 1, 5, 10 and 20 ppm) was added as ZnCl 2 . ZnBG conditioned medium (ZnBG-CM) was prepared by immersing 75mg of glass powders in 50ml DMEM for set periods of time. Before being added to the cells, ZnBG-CM was filter-sterilized, serum and antibiotics were added and equilibrated to 37 o C, 10% CO 2 in an incubator.
Cells between passages 3-5 were used in all experiments. For cell proliferation, MTT and ALP activity assays, 1000 cells/well were seeded in 96-well plates and cultured for 1, 4, 7 and 10 days. 1×10 5 cells/dish and 2×10 4 cells/well were placed in 10cm dishes and 6-well plate for Western blot and qPCR studies, respectively. 5×10 3 cells were seeded onto sterilised coverslips and placed in 12-well plates for immunocytochemistry. 24-wells plate with 5×10 3 cells/well was used for the mineralisation study.
MTT activity assay
The MTT activity assay reflects mitochondrial activity-an indication of viable cells. After rinsing twice with PBS, 50μl of MTT solution (5mg/ml MTT in PBS) was added to cell cuture and incubated for 4 hrs at 37°C. After this, medium was removed and the formazan was solubilised in 100μl dimethyl sulfoxide (DMSO). The absorbance of the solubilised formazan supernatant was measured at 560nm.
Quantitative assay of ALP activity
Alkaline phosphatase (ALP) activity was measured by adding 100μl of ALP reaction solution (20mg 4-Nitropheyl-phosphate disodium salt hexahydrate tablet dissolved in 8ml Tris buffer solution (pH=9.5) containing 15μl of 2M MgCl 2 ) to cell lysate, incubated in the dark at 37 o C for 1 hr. Afterwards, the reaction was stopped by adding 50 μl of 1M NaOH. The absorbance of the supernatant was measured at 405nm and ALP activity was calculated according to a standard curve (Fig.S1 ).
Crystal violet staining
Cells were fixed with 10% neutral buffered formalin for 15 min, rinsed twice with PBS and stained in 0.5% (w/v) crystal violet for 15 min at room temperature.
Before visualising, the unbound stains were removed by extensive washing in PBS.
Western Blot analysis
Cell pellets were re-suspended in RIPA buffer (containing 1% Triton X-100 and 1% cocktail proteinase inhibitors) and the protein content measured using DC™ Protein Assay. Intracellular expression of dentin sialophosphoprotein (DSPP), dentin matrix acidic phosphoprotein 1 (DMP-1) and vascular endothelial growth factor (VEGF) was evaluated by Western blotting using indicated antibodies (Table. A.1) on a PVDF membrane. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the loading control. Cell culture supernatant was also collected and analysed for DSPP and DMP-1 secretion, Coomassie blue was used to visualise sample separation. The band densities were quantified by ImageJ software.
Immunocytochemistry
4% paraformaldehyde in PBS was used to fix the cells. Subsequently, cells were permeablised with 0.1% Triton X-100 for 10 min, and incubated with 10% goat serum for 30 min to block nonspecific binding. Following 1 hr incubation in primary antibody (Table.S1 ) at room temperature, cells were washed and incubated with secondary antibody for 1 hr and counter stained with DAPI.
Finally, the cells were mounted on slides and viewed under confocal microscopy (LSM710, Zeiss). The images were then analysed with ImageJ software.
Quantitative real-time polymerase chain reaction-qPCR
Message RNA (mRNA) was isolated from cells with Dynabeads® (Thermo Fisher Scientific) and reverse-transcribed into cDNA using Transcriptor cDNA Synthesis Kit (Roche). The forward and reverse primers used for PCR were designed by Roche universal probe library according to the complementary DNA sequences available in GenBank (Table.S2 
Alizarin Red S staining
After 3, 4 and 5 weeks culture, cells were fixed in 4% glutaraldehyde for 30min and stained with 2% Alizarin Red S (Sigma-Aldrich) for 1 hr at room temperature. After three washes in dH 2 O to remove unbound stain, samples were air-dried and photographed. For quantification, the bound stain was extracted with 10% cetylpyridinum chloride, and the absorbance of solution was measured at 560 nm.
Scanning electron microscope (SEM)
Cells were fixed in 2.5% glutaraldehyde for 1 hr and dehydrated in graded ethanol (50%, 70%, 80%, 90%, 95%, and 100%), followed by critical-point drying with hexamethyldisilazane. The samples were coated with carbonate and viewed using SEM with an energy-dispersive X-ray (EDX) detector operated from 10-20 kV to scan and analyse mineralised nodule formation and composition.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5. All data were collected from three independent experiments and presented as mean ± standard deviation (SD). Differences were considered significant at p<0.05, determined using one-way ANOVA with Bonferroni's post hoc multiple comparison test.
Results
Low dose Zn increases hDSPCs proliferation and ALP activity
Cells were treated with Zn (0.5 to 20 ppm) for 1, 4, 7 and 10 days. Zn at low concentrations (0.5 and 1 ppm) showed no significant effect on cell proliferation (Fig.1A) as determined by MTT activity assays. Zn at 5 ppm significantly increased (*p<0.05) cell proliferation. However, Zn at high doses (10 and 20 ppm) significantly reduced (*p<0.05) both cell proliferation. A significant increase (*p<0.05) in ALP activity is observed at low concentrations of Zn (0.5 and 1 ppm) treatment for 7-10 days (Fig.1B) . At 20 ppm, Zn reduced ALP activity (Fig.1B) due to increased cytotoxicity as visualised by crystal violet staining (Fig.1C) .
Characterisation of ZnBGs
The amorphous nature of the ZnBGs was indicated by broad peaks in the XRD patterns (Fig.2B) . Similar particle size distribution was confirmed by particle size analysis (Fig.S2A) .
To evaluate bioactivity of the ZnBGs, immersion in Tris buffer was performed.
An increase in pH was measured after immersion (Fig.S2B) . The XRD and FTIR studies confirmed that Zn incorporation retards apatite formation in a dose-dependent manner (Fig.2C-F) . Consistent with XRD findings, the FTIR data also suggested that Zn delays apatite formation (Fig.S3) . ICP-OES analysis revealed rapid release of P and Ca ions from the glass within the first 6 hrs of immersion, these were then incorporated into apatite, hence the reduction of measurable levels. The concentration of Si increased continuously due to the continuous glass dissolution. Interestingly, no particular release pattern was observed for Zn ( Fig. 2G-J) , but the Zn concentration in all samples was less than 1ppm. (Fig. 3B) .
To further investigate the influence of ZnBGs on the odontogenic differentiation of hDPSCs, the regulation of two odontogenic markers -DSPP and DMP-1 was determined by Western blot and immunocytochemistry. As shown in Fig.3C , multiple bands were detected in DSPP and DMP-1 immunoblotting, that are indicative of protein processing as reported previously [18] . Densitometry analysis revealed that intracellular DSPP levels were significantly increased (*p<0.05) upon all ZnBG-CM treatment and intracellular DMP-1 levels were only enhanced in Zn2 and Zn3 BG-CM treatment for 7 days in culture. However, prolonged treatments that extend for 14 days suggested a reduction in intracellular DSPP and DMP-1 levels (Fig.3D) . Immunoblotting of cell culture supernatant reflected the secretion of these two proteins (Fig.3E) , where only DMP-1, but not DSPP, secretion is significantly increased (*p<0.05) following ZnBG-CM treatment (Fig.3F ).
Immunocytochemistry and confocal microscopy analysis demonstrated that DSPP is localised to nucleus and perinuclear region (confirmed by co-staining with the Golgi marker GM130, Fig.4A and C) . Further, DSPP localisation to Golgi was induced following ZnBG-CM treatment ( Fig.4B and C) . DMP-1 is shown to be localised in both cytosol and nucleus (Fig.4A ) and no change in its localisation pattern is induced by ZnBG-CM treatment (Fig.S4). 
ZnBG induces mineralisation of hDPSCs
The mineralisation potential of hDPSCs following ZnBG-CM treatment was assessed by Alizarin Red S that stains Ca 2+ deposits red (Fig.5A) .
Quantification of the staining demonstrated significant increases (*p<0.05) in the staining induced by treatment with Zn1, Zn2 and Zn3 BG-CM by week 3, 4 and 5 in comparison to the glass free control group. SEM scans revealed that the mineralised nodules generated by hDPSCs were between 50 and 100µm in diameter and were raised from the culture surface (Fig.5C) . EDX spectra for calcium and phosphate content in the mineralised nodules indicated a ratio of Ca:P similar to that of hydroxyapatite (~1.6, Fig.5C ).
ZnBG modulates mineralisation-associated gene expression
Further regulation of mineralisation-related differentiation markers of hDPSCs was investigated by qPCR. This analysis revealed up-regulation of BSP and MEPE by day 7 and 14 following all conditions of ZnBG-CM treatment ( Fig. 5G and H). High expression levels of RUNX2 and BMP-2 were detected for Zn1, Zn2 and Zn3 groups but not Zn0 group. Differential expression was observed for ON, when compared to other groups, and OCN is increased only by groups Zn0 and Zn3 at day 7. However, by day 14, the mRNA level of all the genes was up-regulated following ZnBG-CM treatment irrespective of the Zn content ( Fig.5D-I ).
ZnBG modulation of VEGF levels
Following ZnBG-CM treatment immune blotting and densitometry analysis revealed that Zn1 and Zn3 groups clearly enhanced intracellular VEGF levels in hDPSCs after 7 days. Furthermore, by day 14 the expression of VEGF was significantly increased (*p<0.05) in all ZnBG-CM treatments (Fig 5J-K) .
Discussion
The use of 45S5® BG in regenerative endodontics for pulp capping demonstrated the formation of a reparative dentine bridge [19, 20] . The amorphous BG is generally more soluble and reactive than crystalline materials, such as calcium phosphate, thereby enhancing the bioactivity of the material. In addition, BGs can be manufactured to release 'therapeutic' ions, which may induce accelerated formation of mineralised tissues. As Zn is already widely used in dentistry, we have investigated the effect of ZnBGs on differentiation and mineralisation of hDPSCs.
Initially, the safe range of free Zn ion was accessed in cultures of hDPSCs. Cell proliferation and ALP activity assays suggested that low dose Zn, from 0 to 5 ppm, is not cytotoxic and induces the proliferation and differentiation of hDPSCs.
High concentrations (10 and 20ppm) are toxic (Fig. 1) . These findings suggested that ZnBG might also be able to positively modulate hDPSCs odontogenic behaviour.
The influence of Zn on the bioactivity process and its role in BG structure has been extensively debated in literature [21] . ZnO can either act as a modifier leading to a decrease in surface area and pore size of the BG [22] . ZnO can also act as an intermediate oxide forming covalent links between adjacent SiO 4 tetrahedra [23] to create a more stable glass structure. In this study, Zn was added to the BGs assuming that it behaves entirely as an intermediate oxide.
The ZnBGs were successfully synthesised as amorphous structures. The bioactivity of these ZnBGs was quantified (assessed by apatite formation) when immersed in a relevant physiological fluid. [24] . XRD and FTIR findings both confirmed that Zn addition to BG delays the apatite formation in a dosedependent manner (Fig. 2 ). This agrees with previous findings, where delayed apatite formation was due to an increase in the network polymerisation with the incorporation of Zn [25] .
To determine any biological effect, ZnBG-CMs were used in cell culture. At early time points (1 and 4 days), ZnBG-CMs showed no effect on cell proliferation, thereafter increased cell proliferation was observed by day 7 and 10 ( Fig. 3) . These findings indicate that these novel ZnBGs have no significant cytotoxic effects on hDPSCs, confirming the possible utilisation of these materials in tissue repair. The observed increase in ALP activity with ZnBG treatment over time indicates the differentiation potential of hDPSCs and confirmed by the subsequent increase in mineralisation (Fig. 3) .
Protein levels of the odontogenic markers DSPP and DMP-1 were quantified to determine odontogenic differentiation of hDPSCs following ZnBG-CM treatment (Fig. 3) . DSPP and DMP-1 are both involved in the nucleation and formation of HA during dentine formation [26] . Multiple bands were observed in DSPP and DMP-1 blotting, that reflect small functional cleavage products: dentine sialoprotein (DSP) and dentine phosphoprotein (DPP) [26] . Densitometry analysis revealed DSPP levels were increased by day 7 and reduced by day 14.
Meanwhile, immunocytochemistry and confocal microscopy analysis revealed DSPP localisation to Golgi was induced upon ZnBG-CM treatment (Fig. 4) . This implies that ZnBG increases intracellular DSPP protein levels, and subsequently processed in Golgi as reported previously [18] . Increases in DMP-1 levels and secretion are detected as two fragments: N-terminal (37kDa) and C-terminal fragments (57kDa) [26] , was also observed following ZnBG-CM treatment (Fig.4E) . However, no changes in DMP-1 cellular localisation were observed in response to ZnBG-CM treatment. These findings lend support to the idea that ZnBGs in part induce odontogenic differentiation of hPDSCs. PCR analysis also revealed increase in both DSPP and DMP-1 mRNA expression along with osteogenic markers (RUNX2, BMP1, BSP, ON, OCN, and MEPE), which are crucial genes associated with critical roles in mineralisation [27] [28] [29] .
These results are consistent with previous investigation showing that Zn added BG granules stimulate growth and osteogenic differentiation of MSCs via regulation of ALP activity and BSP expression [30] . Together, these findings suggest that ZnBGs can enhance differentiation of hDPSCs in a fashion similar to osteoblast differentiation. This in turn impacts on the mineralisation potential of hDPSCs, as observed in our studies by Alizarin Red S staining and SEM-EDX (Fig. 5) . Moreover, western blot analysis reveals that the expression of VEGF is increased following ZnBG-CM treatment. This is in agreement with a previous report that VEGF plays an essential role in the regulation of mineralisation by stimulating differentiation of MSCs [31] . VEGF has also been confirmed to promote odontogenic differentiation of hDPSCs in vitro [32, 33] .
In a similar study, the stimulation of odontogenic differentiation of dental pulp cells following ZnBG incorporated cement treatment was reported. In addition, this ZnBG incorporated cement up-regulated the expression of VEGF and the increased the tubular structure in endothelial cells [34] . The findings in present study, in consistent with the previous investigation [34] , clearly indicate that ZnBGs can promote the generation of mineralised nodules via up-regulation of VEGF in both osteogenic and odontogenic differentiation pathways in hDPSCs.
It also raises the question, what effect are clinical treatments that contain Zn having on the local cells, and especially odontoblasts?
Conclusion
Stem cell-based regenerative endodontics is a new and exciting field that has the potential to transform the dental practice. In this study, novel zinc containing bioactive glasses were successfully designed and synthesised. Biological studies demonstrated activity of the odonto/osteogenic and VEGF pathways that might be the mechanism by which Zn induces the differentiation of hDPSCs.
This study raises the intriguing possibility of using ZnBGs as therapeutic scaffolds in regenerative endodontics.
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